Compile Data Set for Download or QSAR
Report error Found 53 Enz. Inhib. hit(s) with all data for entry = 10078
TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512366(US11084824, Example 21)
Affinity DataIC50: 0.200nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512364(Preparation of N3-(2,6-dimethylphenyl)-N6-(1,2,3,4...)
Affinity DataIC50: 0.300nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512368(US11084824, Example 23)
Affinity DataIC50: 0.300nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512369(US11084824, Example 24)
Affinity DataIC50: 0.300nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512370(US11084824, Example 25)
Affinity DataIC50: 0.300nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512367(US11084824, Example 22)
Affinity DataIC50: 0.400nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512363(US11084824, Example 18)
Affinity DataIC50: 0.5nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512351(US11084824, Example 2 | US11084824, Example 20)
Affinity DataIC50: 0.5nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512388(US11084824, Example 53)
Affinity DataIC50: 0.523nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512350(US11084824, Example 1)
Affinity DataIC50: 0.600nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512351(US11084824, Example 2 | US11084824, Example 20)
Affinity DataIC50: 0.600nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512360(Preparation of N3-(2,6-dichlorophenyl)-1-methyl-N6...)
Affinity DataIC50: 0.670nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512377(US11084824, Example 32)
Affinity DataIC50: 0.700nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512392(Preparation of N3-(2,6-dimethylphenyl)-N6-(isoindo...)
Affinity DataIC50: 0.745nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512354(US11084824, Example 7)
Affinity DataIC50: 0.800nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512376(US11084824, Example 31)
Affinity DataIC50: 0.800nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512390(Preparation of N3-(2,6-dimethylphenyl)-1-methyl-N ...)
Affinity DataIC50: 0.847nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512355(US11084824, Example 8)
Affinity DataIC50: 1nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512372(US11084824, Example 27)
Affinity DataIC50: 1nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512397(US11084824, Example 61)
Affinity DataIC50: 1.03nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512389(Preparation of 4-(3-((2,6-dimethylphenyl)amino)-6-...)
Affinity DataIC50: 1.14nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512362(US11084824, Example 17 | US11084824, Example 62)
Affinity DataIC50: 1.20nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512362(US11084824, Example 17 | US11084824, Example 62)
Affinity DataIC50: 1.21nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512386(US11084824, Example 48)
Affinity DataIC50: 1.28nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512387(US11084824, Example 49)
Affinity DataIC50: 1.61nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512394(Preparation of N6-(1,1-dimethyl-1,2,3,4-tetrahydro...)
Affinity DataIC50: 1.69nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512383(US11084824, Example 44)
Affinity DataIC50: 1.70nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512395(US11084824, Example 59)
Affinity DataIC50: 1.84nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512371(US11084824, Example 26)
Affinity DataIC50: 2nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512375(US11084824, Example 30)
Affinity DataIC50: 2nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512359(US11084824, Example 14)
Affinity DataIC50: 2nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512399(US11084824, Example 63)
Affinity DataIC50: 2.13nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512382(US11084824, Example 39)
Affinity DataIC50: 2.80nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512384(US11084824, Example 46)
Affinity DataIC50: 2.85nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512361(US11084824, Example 16)
Affinity DataIC50: 3nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512380(US11084824, Example 35)
Affinity DataIC50: 3nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512373(US11084824, Example 28)
Affinity DataIC50: 3nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512358(US11084824, Example 13)
Affinity DataIC50: 3nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512357(US11084824, Example 12)
Affinity DataIC50: 3.75nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512396(US11084824, Example 60)
Affinity DataIC50: 4.01nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512378(US11084824, Example 33)
Affinity DataIC50: 5nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512400(US11084824, Example 64)
Affinity DataIC50: 5.22nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512385(US11084824, Example 47)
Affinity DataIC50: 5.42nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512401(US11084824, Example 65)
Affinity DataIC50: 7.74nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512374(US11084824, Example 29)
Affinity DataIC50: 8nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512402(N3-(2,6-dimethylphenyl)-1-methyl-N6-(4-(piperidine...)
Affinity DataIC50: 10nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512353(US11084824, Example 6)
Affinity DataIC50: 10nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512379(US11084824, Example 34)
Affinity DataIC50: 15nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512403(1-(4-(4-(3-(2,6-dimethylphenylamino)-1-methyl-1H-p...)
Affinity DataIC50: 20nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Korea Research Institute of Chemical Technology

US Patent
LigandPNGBDBM512393(Preparation of 1-(4-methyl-3-((1-methyl-6-((1,2,3,...)
Affinity DataIC50: 26.7nMAssay Description:BTK enzyme evaluation with each compound of examples of the invention was performed by using BTK enzyme inhibition diagnosis kit (Cisbio, Codolet, Fr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/24/2022
Entry Details
US Patent

Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: